- Home
- CTNT vs VIVS Comparison
CTNT vs VIVS Comparison
Compare CTNT & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNT
- VIVS
- Stock Information
- Founded
- CTNT 2016
- VIVS 2007
- Country
- CTNT United States
- VIVS United States
- Employees
- CTNT N/A
- VIVS N/A
- Industry
- CTNT
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CTNT
- VIVS Health Care
- Exchange
- CTNT Nasdaq
- VIVS Nasdaq
- Market Cap
- CTNT 5.5M
- VIVS 4.7M
- IPO Year
- CTNT 2023
- VIVS N/A
- Fundamental
- Price
- CTNT $1.83
- VIVS $3.69
- Analyst Decision
- CTNT
- VIVS
- Analyst Count
- CTNT 0
- VIVS 0
- Target Price
- CTNT N/A
- VIVS N/A
- AVG Volume (30 Days)
- CTNT 28.2K
- VIVS 868.7K
- Earning Date
- CTNT 11-12-2025
- VIVS 11-07-2025
- Dividend Yield
- CTNT N/A
- VIVS N/A
- EPS Growth
- CTNT N/A
- VIVS N/A
- EPS
- CTNT N/A
- VIVS N/A
- Revenue
- CTNT $1,119,333.00
- VIVS $142,000.00
- Revenue This Year
- CTNT $302.80
- VIVS $42.38
- Revenue Next Year
- CTNT $22.22
- VIVS $15.42
- P/E Ratio
- CTNT N/A
- VIVS N/A
- Revenue Growth
- CTNT N/A
- VIVS 94.52
- 52 Week Low
- CTNT $1.12
- VIVS $1.41
- 52 Week High
- CTNT $8.50
- VIVS $21.96
- Technical
- Relative Strength Index (RSI)
- CTNT 59.64
- VIVS 62.32
- Support Level
- CTNT $1.73
- VIVS $3.29
- Resistance Level
- CTNT $2.00
- VIVS $5.30
- Average True Range (ATR)
- CTNT 0.10
- VIVS 0.63
- MACD
- CTNT 0.01
- VIVS 0.16
- Stochastic Oscillator
- CTNT 58.54
- VIVS 52.74
About CTNT Cheetah Net Supply Chain Service Inc.
Cheetah Net Supply Chain Service Inc is a one-stop services including Warehousing, Logistics, International trading & Supply Chain Finance, Etc. It operate in single segment Logistics and warehousing services which focuses on providing freight forwarding services for clients shipping goods from the U.S. to mainland China or Hong Kong. Its services include: (i) cargo storage, (ii) freight forwarding, (iii) U.S. customs clearance, and (iv) labor services and cargo loading and unloading.
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.